New Dimensions and Landmark Practice Advances in Hypertension and Heart Disease WebCAST

WebCAST CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

November 5, 2008

Expiration Date:

November 5, 2010

Intended Audience:

• Primary Care Physicians
• Hypertension Specialists
• Internists
• Preventive Medicine Specialists
• Family Medicine Specialists
• Cardiologists
• Nurse Practitioners
• Physician Assistants
• Pharm.D’s
• Clinical Pharmacists
• Residents and Fellows

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from Forest Pharmaceuticals, Inc

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Kenneth A. Jamerson – Program Chairman
Grant/Research: NIH, NHLBI, NIDDK, Novartis, King
Consultant: Abbott, BMS, GSK, King, Merck, Novartis, Sankyo, sanofi-aventis
Speaker’s Bureau: BMS, Merck, Novartis
Other: Act on behalf of the International Society of Hypertension in Blacks (ISHIB,) as president, to obtain industry support

Henry R. Black, MD
Grant/Research: Pfizer
Consultant: Pfizer, Sankyo, MSD, BI, BMS/Sanofi, Novartis, Myogen
Speaker’s Bureau: Sankyo, BI, Novartis, Pfizer

L. Michael Prisant, MD, FACP, FACC, FAHA
Grant/Research: Astra-Zeneca, Abbott, Boerhinger-Ingelheim, Eli-Lilly, Novartis
Consultant: Astra-Zeneca, Abbott, CV Therapeutics, Merck, Merck/Schering-Plough, Reliant, Schwarz, SunTech MedicalSpeaker’s Bureau: Astra-Zeneca, Abbott, Boerhinger-Ingelheim, CV Therapeutics, Merck, Merck-Schering-Plough, Reliant

Program Faculty:

Program Chairman
Kenneth A. Jamerson – Program Chairman
Professor of Internal Medicine
Cardiovascular Medicine
University of Michigan Medical School
Medical Director, Program of Multi-Cultural Health
University of Michigan
Ann Arbor, MI

Henry R. Black, MD
Clinical Professor of Medicine
New York University Medical Center
New York, NY

L. Michael Prisant, MD, FACP, FACC, FAHA
Professor of Medicine
Medical College of Georgia
Director of Hypertension & Lipid Clinic
Augusta, GA

Educational Objectives:

Participants in this CME-certified WebCAST will:

• Learn how to approach hypertension as a systematic disease, with multiple manifestations, and associations, including as sessment of coexisting conditions that support use of specific classes or agents.
• Learn about the complications linked to healthcare disparities observed in specific patient populations, and the importance of providing access, treatment, and monitoring of patients with multiple risk CV risk factors.
• Learn how to manage complicated patients with high blood pressure, including those with ischemic heart disease and/or heart failure.
• Learn the importance of early treatment of patients with high blood pressure, markers to look for, and the importance of treat ing both systolic and diastolic blood pressure abnormalities.
  
  

Disclaimer:

Copyright © 2008 by Pharmatecture, LLC. All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2008 All rights reserved